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In a recent study in Nature, Bonfanti et al. (2010) report that the skin microenvironment can convert thymic
epithelial cells into skin stem cells. This finding suggests that somatic stem cellsmay have a broader potential
for lineage switching than previously thought.The discovery that lineage-restricted so-
matic cells could be reprogrammed into
an embryonic stem cell (ESC)-like state
through ectopic expression of defined
transcription factors (Takahashi and Ya-
manaka, 2006) has opened up new
avenues for regenerative medicine. This
finding has also shifted the focus of the
research community toward studying
pathways that would allow adult stem
cells committed to specific differentiation
fates to give rise to specialized cell types
of another tissue, a phenomenon referred
to as cell plasticity, transdifferentiation, or
lineage reprogramming (Anderson et al.,
2001; Zhou and Melton, 2008). The extent
and the mechanisms of somatic stem cell
plasticity are yet to be determined. How-
ever, the direct alteration of gene expres-
sion (by the insertion of exogenous genes,
for example) is obviously a potent inducer
of cell fate switching, as shown for the
generation of induced pluripotent stem
cells (iPSCs) (Takahashi and Yamanaka,
2006) or reprogramming of fibroblasts
into neurons (Vierbuchen et al., 2010) or
cardiomyocytes (Ieda et al., 2010).
Whether the extracellular environment
alone is sufficient to reprogram geneti-
cally intact somatic cells is still open to
question. In a recent issue ofNature, Bon-
fanti and colleagues now show that un-
modified epithelial cells isolated from the
thymus, a specialized organ of the im-
mune system, can function as skin stem
cells following the exposure to a skin-like
microenvironment (Bonfanti et al., 2010).
The thymus plays a critical role in T
lymphocyte development, ensuring that
mature T cells do not mount a pathogenic
immune response to the body’s own
tissues while they effectively attack anddestroy foreign agents. The thymus is
composed of a variety of epithelial and
nonepithelial populations that are orga-
nized into two main compartments:
cortex and medulla. An increasing num-
ber of reports demonstrate that thymic
epithelial cells (TECs) residing in the
medulla constitute a site for the promis-
cuous transcription of a great number of
genes that encode non-thymic tissue-
restricted antigens. Such promiscuous
gene expression is thought to mediate
self-tolerance in the developing T cell
repertoire by providing a broad range of
tissue-specific antigens used to select
against thymocytes that exhibit a strong
affinity for self antigens (Kyewski and
Derbinski, 2004).
The promiscuous gene expression
observed in medullary TECs may poten-
tially make these cells prone to fate
switching if proper morphogenetic signals
were provided. To address this possi-
bility, Bonfanti and colleagues exposed
epithelial cells from rat thymus to a skin
microenvironment. TECs were isolated
from embryonic, postnatal, or adult thy-
mus, sorted for the expression of epithe-
lial cell adhesion molecule (EpCAM) and
cultured under conditions used to grow
skin cells on lethally irradiated 3T3 feeder
layers. Under these conditions, sorted
TECs were able to form progressively
growing colonies. Interestingly, serial
cultivation of isolated TECs predomi-
nantly selected for clones that exhibited
a medullary phenotype, as determined
by the expression of the transcription
factor p63 and keratins 5 and 14 (Laster
et al., 1986). Note that keratins 5 and 14,
as well as p63, are also the markers indic-
ative of ectodermally derived epithelialCell Stem Cellcells that have committed to a stratified
epithelial fate (Koster et al., 2004).
Although the culturing of TECs under
skin stem cell conditions turned on the
expression of many other genes linked
to epidermal and hair follicle differentia-
tion, such as involucrin and LEKTI, colo-
nies of TECs were morphologically dif-
ferent from skin stem cells. Furthermore,
the cultured TECs continued to express
key factors required for TEC maintenance
and participated in thymic morphogen-
esis when implanted as aggregates with
freshly isolated thymic cells under the
kidney capsule of athymic mice. The
extensive self-renewal of cultured TECs
and their capacity to reconstitute a thymic
epithelial network expressing MHC-class
II and Aire suggest that the TECs isolated
by Bonfanti and colleagues represent
bona fide thymic epithelial stem cells.
However, while maintaining their TEC
identity, the same cultured TECs were
also capable of contributing to the forma-
tion of the epidermis and hair follicles in a
short-term reconstitution assay and could
also participate in long-term epidermal
renewal.
For the long-term in vivo assay, clono-
genic TECs were introduced into a small
pocket generated between the epidermis
and dermis of newbornmouse skin, which
was subsequently transplanted under-
neath a skin flap on athymic mice. The
authors then recovered TEC-derived cells
from the skin grafts and analyzed these
cells for skin stem cell characteristics.
Surprisingly, although the ex vivo skin
microenvironment was not sufficient to
completely reprogram TECs into actual
skin stem cells, the subsequent exposure
of the cultured TECs to an in vivo skin7, October 8, 2010 ª2010 Elsevier Inc. 419
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Figure 1. Possible Sources of Tissue-Specific Stem Cells for
Regenerative Medicine
Regenerative medicine is still searching for an ideal stem cell candidate.
Embryonic stem cells (ESCs) give rise to cells from all three germ layers and
may seem to be the most ideal source of tissue-specific stem cells. However,
ethical/political concerns, the risk of tumor formation, and the possibility of
immune rejection of the tissues derived from allogeneic ESCs have hindered
the therapeutic application of ESCs. The generation of induced pluripotent
stem cells (iPSCs) from patient-specific cells addresses many of the concerns
that have plagued the use of ESCs; however, there are safety concerns
associated with reprogramming that have not yet been resolved. The phenom-
enon of somatic stem cell plasticity (or transdifferentiation), i.e., the ability of
tissue-specific stem cells to give rise to stem cell types of other organs, offers
a novel source of stem cells applicable for regenerative medicine. The use of
adult cells for therapy would (1) avoid ethical/political and immunological
concerns given that the cells would be derived from the patient in need of
treatment and (2) potentially reduce the risk of tumor formation, which might
occur if residual undifferentiated ESCs or iPSCs were transplanted.
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Previewsenvironment irreversibly con-
verted them into multipotent
skin stem cells (called sr1-
TECs), as determined by
robust changes in gene ex-
pression, their ability to form
hair follicles and epidermis in
secondary skin reconstitution
assays, and their inability
to reconstitute thymic epithe-
lium.
Importantly, whereas bona
fide hair follicle stem cells
can only renew the epidermis
for 3 weeks in response to
injury, sr1-TECs were proven
effective in regenerating hair
follicles and the epidermis
for up to a year after trans-
plantation. This observation
may have important clinical
implications. For example,
TECs may provide an alterna-
tive source of autologous skin
stem cells applicable for gene
therapy. This potential is es-
pecially important for patients
with inherited skin blistering
diseases, such as epidermol-
ysis bullosa, who exhaust
their epidermal stem cells
because of constant wound
repair as a result of blistering
(Mavilio et al., 2006). Given
that involution of the thymusoccurs with age, the use of TECs as an
alternate source of skin stem cells may
be limited to the treatment of children
prior to puberty. However, it is possible
that residual TECs reside in the involuted
thymus, and this issue can be experimen-
tally addressed by the approaches
described in Bonfanti et al.
Given the considerable interest in ex-
ploiting stem cell plasticity for therapeutic
applications (Figure 1), the findings of
Bonfanti and colleagues emphasize the
possibility of reprogramming one cell
type to another without needing to dedif-
ferentiate through an intermediate iPSC
state (Zhou and Melton, 2008). Further-
more, the current findings suggest that
the introduction of exogenous reprogram-
ming factors can be avoided altogether, at420 Cell Stem Cell 7, October 8, 2010 ª2010least for the conversion of endoderm-
originated thymic epithelium into ecto-
derm-derived skin tissue. However, it
remains to be seen whether the cultured
TECs represent restricted stem cells that
are reprogrammed across lineage bound-
aries by themicroenvironment, or a popu-
lation of less committed stem cells with
inherently broad multilineage potential
that is dependent on morphogenetic sig-
nals. In either case, promiscuous gene
expression by medullary TECs may
make this population prone to switching
their fate in response to microenviron-
mental cues from other tissues. If so,
thymic stem cells may offer a universal
source of primitive patient-specific multi-
potent stem cells for tissue regeneration.
However, such expanded potential mayElsevier Inc.carry a risk of tumor formation
in a clinical setting, high-
lighting the need to better
understand the mechanisms
that regulate the growth and
differentiation of the stem
cells and their progeny.
In summary, the findings
from Bonfanti and colleagues
reinforce the model that
organ-specific stem cells may
be reprogrammed into unex-
pected alternate lineages,
when exposed to appropriate
exogenous factors. Given
that the clinical application of
ESCs has been hindered by
intense ethical/political and
technical challenges, and that
reprogrammed iPSCs still
harbor significant safety con-
cerns, the ability to control
fate switching of somatic
stem cells by microenviron-
mental cues may provide a
new driving force to move the
field of regenerative medicine
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